United Arab Emirates (UAE) Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Figure 1: Pharmaceutical market, revenue ($B), UAE, 2016–22

Figure 2: Medical device market, revenue ($B), UAE, 2016–21

Figure 3: Healthcare startups in UAE, 2022

Figure 4: Country profile, UAE, 2022

Figure 5: Pharmaceutical market, revenue ($B), UAE, 2016–21

Figure 6: Pharmaceutical market, revenue forecast ($B), UAE, 2022–27

Figure 7: Pharmaceutical exports ($M), UAE, 2014–20

Figure 8: Top export partners, UAE, 2020

Figure 9: Pharmaceutical imports ($B), UAE, 2014–20

Figure 10: Top import partners, UAE, 2020

Figure 11: Pharmaceutical distribution channels, UAE, 2021

Figure 12: Tatmeen, a track-and-trace platform, UAE, 2021

Figure 13: Major generic medicine manufacturers, UAE, 2021

Figure 14: OTC medicines market, revenue ($M), UAE, 2014–21

Figure 15: OTC medicines market, major distribution channels ($M), UAE, 2021

Figure 16: OTC market by sub-categories of drugs, revenue ($M), UAE, 2021

Figure 17: Major therapeutic areas, % (value), UAE, 2021

Figure 18: Major therapeutic areas, % (volume), UAE, 2021

Figure 19: COVID-19 (number of cases), UAE, 2020–22

Figure 20: COVID-19 (number of deaths), UAE, 2020–22

Figure 21: Stringency index, COVID-19, UAE, 2020–22

Figure 22: Containment and health index, COVID-19, UAE, 2020–22

Figure 23: COVID-19 Fiscal stimulus packages, UAE, 2020–21

Figure 24: COVID-19 Vaccine doses administration, number of vaccine doses administered, UAE, 2022

Figure 25: COVID-19 Vaccine booster doses administration, number of vaccine doses administered per 100 people, UAE, 2022

Figure 26: Top COVID-19 markets by product categories (number of available marketed products), UAE, 2020–22

Figure 27: Top COVID-19 products by equipment type (number of available marketed products), UAE, 2020–22

Figure 28: Companies manufacturing COVID-19 NAATS and POC tests (number of available marketed products), UAE, 2020–22

Figure 29: Top COVID-19 Nucleic acid amplification tests by equipment type (number of available marketed products), UAE, 2020–22

Figure 30: COVID-19 clinical trial sponsors by trial count, UAE, 2020–22

Figure 31: COVID-19 clinical trials count by phase, UAE, 2020–22

Figure 32: COVID-19 clinical trials count by trial status, UAE, 2020–22

Figure 33: Medical devices market, revenue ($B), UAE, 2016–21

Figure 34: Medical devices market, revenue forecast ($B), UAE, 2022–27

Figure 35: Medical devices market, major segments (%), UAE, 2021

Figure 36: Hospital supplies market, revenue ($M), UAE, 2016–27

Figure 37: Orthopedic devices market, revenue ($M), UAE, 2016–27

Figure 38: General surgery market, revenue ($M), UAE, 2016–27

Figure 39: Cardiovascular devices market, revenue ($M), UAE, 2016–27

Figure 40: Neurology devices market, revenue ($M), UAE, 2016–27

Figure 41: Diagnostics market, revenue ($M), UAE, 2016–21

Figure 42: Diagnostics market, revenue forecast ($M), UAE, 2022–27

Figure 43: Medical devices market, revenue ($B) of major companies, UAE, 2020

Figure 44: Deal value and deal count, pharmaceutical market, UAE, 2015–21

Figure 45: Deal value and deal count, quarterly, pharmaceutical market, UAE, 2015–21

Figure 46: Deal value and deal count subtypes, pharmaceutical market, UAE, 2015–21

Figure 47: Top therapy areas by deal value ($M), pharmaceutical market, UAE, 2015–21

Figure 48: Top therapy areas by deal count, pharmaceutical market, UAE, 2015–21

Figure 49: M&A deals bi-annually (by value and by number), pharmaceutical market, UAE, 2015–21

Figure 50: Deal value and deal count, medical devices market, UAE, 2015–21

Figure 51: Deal value and deal count, quarterly, medical devices market, UAE, 2015–21

Figure 52: Deal value and deal count subtypes, medical devices market, UAE, 2015–21

Figure 53: Top equipment sectors by deal value ($M), medical devices market, UAE, 2015–21

Figure 54: Top equipment sectors by deal count, medical devices market, UAE, 2015–21

Figure 55: Overview of DOH policy on digital health, UAE, 2020

Figure 56: Deal value ($M) and deal count (number of deals), HealthTech, UAE, 2015–21

Figure 57: Deal value ($M) and deal count (number of deals) by deal sub-category, HealthTech, UAE, 2015–21

Figure 58: Overview of the priority areas of the DOH Policy on the Abu Dhabi Health Information Exchange, UAE, 2020

Figure 59: Organizational structure of healthcare system, UAE, 2021

Figure 60: Issue of a Health Card, UAE, 2021

Figure 61: Drug formulary application requirements, UAE, 2021

Figure 62: Pharmaceutical reimbursement process, UAE, 2021

Figure 63: Out-of-pocket spending ($ per capita and % of health spending), UAE, 2014–21

Figure 64: Annual inflation rate in health price index (% change accumulated in the year),UAE, 2015–21

Figure 65: Distribution of out-of-pocket health expenditure (%), UAE, 2019

Figure 66: Medicine pricing process, UAE, 2021

Figure 67: Pharmaceutical product registration, UAE, 2022

Figure 68: Biosimilar licensing procedure, UAE, 2019

Figure 69: Requirements for registration of medicines derived from natural sources, UAE, 2022

Figure 70: Required documents for registration of medical devices, UAE, 2022

Figure 71: Medical device registration, UAE, 2022

Figure 72: Requirements for pharmaceutical establishment registration, UAE, 2019

Figure 73: Pharmaceutical establishment registration, UAE, 2019

Figure 74: Export of medicines, UAE, 2019

Figure 75: Required documents for import of medicines for personal use, UAE, 2022

Figure 76: Procedure for obtaining an approval for import of medicines for personal use, UAE, 2022

Figure 77: Required documents for import of medicines from a local agent, UAE, 2022

Figure 78: Procedure for obtaining an approval for import of medicines from a local agent , UAE, 2022

Figure 79: Documents required for the import of medical devices, UAE, 2022

Figure 80: Procedure for obtaining an approval for import of medical devices, UAE, 2022

Figure 81: Patent application process, UAE, 2022

Figure 82: Trademark application process, UAE, 2022

Figure 83: Regulatory process for interventional clinical trial approval, UAE, 2021

Figure 84: Regulatory process for non-interventional clinical trial approval, UAE, 2021

Figure 85: Pharmaceutical clinical trials count by trial status, UAE, 2020–22

Figure 86: Pharmaceutical clinical trials count by phase, UAE, 2020–22

Figure 87: Pharmaceutical clinical trials count by indication, UAE, 2020–22

Figure 88: Top five pharmaceutical clinical trials sponsors by count, UAE, 2020–22

Figure 89: Medical devices clinical trials count by trial status, UAE, 2020–22

Figure 90: Medical devices clinical trials count by indication, UAE, 2020–22

Figure 91: Medical devices clinical trials count by device category, UAE, 2020–22

Figure 92: Top five medical devices clinical trials sponsors by count, UAE, 2020–22

Figure 93: Advertisement service approval, UAE, 2019

Figure 94: Packaging and labeling information, UAE, 2021

Figure 95: Number of hospitals, UAE, 2014–21

Figure 96: Number of public and private hospitals, UAE, 2014–21

Figure 97: Number of hospital beds (per 10,000 population), UAE, 2014–21

Figure 98: Number of CT scanners and MRI units, UAE, 2015–21

Figure 99: Life expectancy at birth (years), UAE, 2014–21

Figure 100: Immunizations below one year by type of vaccine, UAE, 2019

Figure 101: Immunization rate (%), UAE, 2014–21

Figure 102: PM2.5 (µg per m3), UAE, 2014–21

Figure 103: CO2 emissions (million tons), UAE, 2014–21

Figure 104: Physicians (per 10,000 population), UAE, 2014–21

Figure 105: Dentists (per 10,000 population), UAE, 2014–21

Figure 106: Pharmacists (per 10,000 population), UAE, 2014–21

Figure 107: Nurses (per 10,000 population), UAE, 2014–21

Figure 108: Major causes of mortality (per 100,000 population), UAE, 2019

Figure 109: Major causes of male mortality (per 100,000 population), UAE, 2019

Figure 110: Major causes of female mortality (per 100,000 population), UAE, 2019

Figure 111: DALYs by major disease (per 100,000 population), UAE, 2019

Figure 112: Healthcare expenditure as percentage of GDP (%), UAE, 2014–21

Figure 113: Health expenditure share (% of total health spending), UAE, 2014–21